Fresenius SE & Co has patented a method for assessing blood product conditions using a smartphone. The process involves capturing an image of a blood container, analyzing it to determine the blood component’s condition, and displaying the results, incorporating a color tag for calibration. GlobalData’s report on Fresenius SE & Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Fresenius SE & Co KGaA - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Fresenius SE & Co, was a key innovation area identified from patents. Fresenius SE & Co's grant share as of July 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.

Smartphone method for assessing blood product characteristics

Source: United States Patent and Trademark Office (USPTO). Credit: Fresenius SE & Co KGaA

The patent US12064397B2 outlines a method and system for assessing the condition of blood components, such as plasma and platelets, that have been separated from whole blood and stored in containers. The method involves using a handheld computing device, such as a smartphone, to capture an image of the blood product container. This image is processed to evaluate the condition of the blood component, with a color tag attached to the container serving as a calibration reference for the image processing algorithm. The system can also scan barcodes on the container to generate unique identifiers, which are stored and can be communicated to a remote database for tracking and management purposes.

Additionally, the handheld device is equipped with a camera, display, and network interface, allowing it to wirelessly transmit the identified condition and container identifier to a remote computer or a memory tag attached to the blood product container. The device can download applications to enhance its functionality, enabling users to easily access the necessary tools for image acquisition and condition assessment. This innovative approach aims to streamline the monitoring of blood components, ensuring better management and traceability within blood establishments.

To know more about GlobalData’s detailed insights on Fresenius SE & Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.